Equine arteritis virus (EAV) is an enveloped, single-stranded, positive-sense RNA virus that belongs to the family *Arteriviridae.* This family also includes porcine reproductive and respiratory syndrome virus (PRRSV), lactate dehydrogenase elevating virus (LDV) and simian hemorrhagic fever virus \[[@CR1]\]. The families *Arteriviridae*, *Coronaviridae*, and *Roniviridae* comprise the order *Nidovirales* \[[@CR2]\]. EAV causes equine viral arteritis, a debilitating disease of horses manifested as a respiratory syndrome and abortion in adults, and interstitial pneumonia in foals \[[@CR1], [@CR3], [@CR4]\].

The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) comprises a family of transcription factors that regulate expression of genes involved in cellular functions such as apoptosis, proliferation, immune responses, inflammation and stress responses, by binding to specific DNA sequences \[[@CR5]\]. Many viruses modulate NF-κB signalling in terms of activation or suppression, or both, at different phases of the virus life cycle \[[@CR6]\]. Porcine respiratory and reproductive syndrome virus, a member of the family *Arteriviridae*, has been shown to activate NF-κB signalling \[[@CR7]\]. Myeloid differentiation primary response gene 88 (MyD88) is an adapter protein that mediates pathogen-induced NF-κB signalling from toll-like receptors (TLRs) to the nucleus, leading to expression of type I interferon (IFN) and inflammatory cytokine genes \[[@CR8], [@CR9]\]. The role of NF-κB signalling in infection with members of the family *Arteriviridae* has not yet been elucidated. Also, the mechanism of NF-κB activation during infection has not been demonstrated with any of the arteriviruses. Therefore, the involvement of MyD88, as a main adaptor molecule in activation of NF-κB signalling, was investigated upon infection with EAV. Also, the effect of NF-κB activation on viral replication was studied in impaired murine cells.

In order to confirm the activation of NF-κB signalling by EAV infection, we used a dual luciferase reporter assay system. Baby hamster kidney 21 (BHK-21, ATCC, CCL-10) cells were co-transfected with an NF-κB reporter plasmid (p-Luc-NF-κB) and pGL 4.74 as transfection control at a concentration of 200 ng and 10 ng, respectively. Six hours post-transfection, the cells were infected with EAV strain SP3A at multiplicity of infection (MOI) of 5. Eighteen hours after infection, the cells were lysed and subjected to Dual-Luciferase Reporter Assay (Promega), and NF-κB dependant luciferase activity was measured using a luminometer (GloMax®-Multi Detection System, Promega). Results of three independent experiments showed that NF-κB was significantly activated by EAV infection (Fig. [1](#Fig1){ref-type="fig"}a). The activation of NF-κB in EAV-infected cells was also confirmed by immunoblotting at 12 and 24 hours post-infection using a rabbit polyclonal antibody (Santa Cruz Biotechnology) against p65 NF-κB phosphorylated at serine 276 as shown in Fig. [1](#Fig1){ref-type="fig"}b.Fig. 1EAV infection activates p65 NF-κB through the MyD88 signaling pathway. (a) NF-κB activation in BHK-21 cells transfected with an NF-κB-dependent luciferase reporter system. Depicted is a representative of three independent experiments, each with three replicates \*\*\*(p\<0.001 by unpaired Student's t-test). A significant difference in luciferase activity was seen between infected and mock-infected or infected cells treated with TGF-β. (b) Detection of phosphorylated p65 by immunoblotting in EAV-infected cells. Idle p65 was detected in infected and uninfected cells, while the signal for phosphorylated p65 (P-p65) NF-κB was stronger in infected cells. (c) TGF-β suppression of MyD88-induced NF-κB activation. BHK-21 cells were transfected with reporter plasmids as before, plus MyD88 plasmid where indicated, and TGF-β was added 8 hours before lysis. A significant reduction in luciferase activity was seen in infected TGF-β-treated cells. (d) Nuclear translocation of p-p65 NF-κB in infected but not in mock-infected BHK-21 cells. A proximity ligation assay (PLA) was performed with an antibody recognizing p65 NF-κB phosphorylated at serine 276 (upper panel). EAV infection was confirmed by the signal for expression of the nucleocapsid protein (EAV N) using immunofluorescence (lower panel)

Moreover, we showed that in presence of MyD88 (200 ng), as an NF-κB stimulus, EAV infection led to a significant increase in NF-κB activity. However, when the cells were pre-treated with TGF-β1 (R&D Systems; 30 ng/ml, 8 hours before cell lysis) EAV infection failed to activate NF-κB (Fig. [1](#Fig1){ref-type="fig"}c). TGF-ß has been shown to inhibit MyD88-dependent NF-κB activation by causing proteasomal degradation of MyD88 and not TRIF \[[@CR10]\]. To show TGF-β1 suppression of the MyD88 pathway in our system, we transfected cells with MyD88 (200 ng) and an NF-κB reporter as before and treated them with TGF-β1 (30 ng/ml). Twenty-four hours after transfection, cells were lysed and subjected to dual luciferase reporter assay. MyD88-induced NF-κB activation was dramatically reduced in TGF-β1-treated cells, indicating that TGF-ß1 suppresses MyD88-dependent NF-κB activation in BHK-21 cells (Fig. [1](#Fig1){ref-type="fig"}c). Therefore, our results suggest that EAV-induced NF-κB activation is MyD88 dependent, because in the presence of TGF-β1, as a MyD88 inhibitor, EAV could not activate NF-κB signalling. MyD88 is an important mediator in the inflammatory response (e.g., NF-κB-induced cytokine production) to infections, but its role has been controversial when studied in some viral infections using MyD88-knockout mice. It has been demonstrated, for example, that MyD88 is essential for defence against primary influenza A virus infection, since MyD88 knockout mice were significantly more susceptible to primary infection \[[@CR11]\]. In contrast, another study demonstrated that functional MyD88 signalling in wild-type mice contributes to coxsackievirus B3 pathogenesis to enhance the virus replication; however, surprisingly, MyD88-deficient mice had higher levels of interferon regulatory factor 3 (IRF3) and interferon β, which are important antiviral elements \[[@CR12]\].

To investigate nuclear translocation of p-NF-κB in EAV infection, BHK-21 cells were infected with EAV SP3A in chamber slides and fixed at 8, 12, 16 and 24 hours post-infection. An *in situ* proximity ligation assay (*in situ* PLA) (Olink Biosciences^®^) was performed following the manufacturer's protocol and using polyclonal rabbit serum (Santa Cruz Biotechnology) against phosphorylated forms of p65 NF-κB, diluted 1:500 in TBS containing 5 % goat serum (TBS-GS) as blocking buffer. EAV infection was demonstrated by immunofluorescence with a monoclonal antibody targeting the nucleocapsid protein in cells infected in parallel wells of chamber slides and fixed as before. Activation and nuclear localization of p65 NF-κB was seen in cells probed with the anti-p-p65 serine 276 antibody but not in uninfected cells (Fig. [1](#Fig1){ref-type="fig"}d). In addition, cells probed with antibodies to forms of p65 NF-κB phosphorylated at serine 536, serine 468, threonine 254 and threonine 435 did not show signals for nuclear translocation (data not shown). The NF-κB family consists of homodimers/heterodimers of five subunits, of which p65 (RelA) is the main subunit of the canonical pathway of NF-κB signalling that is potentially targeted by viruses \[[@CR6]\]. In addition, it is known that the phosphorylation status of NF-κB subunits affects their transcriptional activity \[[@CR13]\]. The role of p65 (RelA) in the immune response to viral infections and in inducing expression of type I IFN genes has been controversial. Besides, there are only few studies on the phosphorylation status of NF-κB during viral infections. Respiratory syncytial virus has been demonstrated to induce phosphorylation of RelA at serine 276 and serine 536^.^ \[[@CR14]\], and that phosphorylation at serine 276 is required for transcription elongation of inflammatory genes \[[@CR15]\]. Even though the majority of classical studies agreed on the substantial role of RelA in type I IFN gene expression, recent studies have challenged this perception \[[@CR16]\]. One study suggested a crucial role for RelA in induction of an IFN response in the early response to RNA viruses \[[@CR17]\]. The outcome of p65 (RelA) activation and its phosphorylation at serine 276 in the context of interferon response during EAV infection needs to be investigated further.

Murine embryo fibroblasts (MEFs) are susceptible to EAV infection \[[@CR18]\], and IKKβ^−/−^ MEFs are significantly deficient in NF-κB activity \[[@CR19]\]. To study the relevance of NF-κB signalling in infection with EAV, wild-type (wt) and IKKβ^−/−^ cells were infected with 10-fold dilutions of EAV strain SP3A. Twenty-four hours after infection, cells were observed for cytopathic effect (CPE) using a bright-field microscope. As depicted in Fig. [2](#Fig2){ref-type="fig"}a, the CPE was reduced in knockout cells (IKKβ^−/−^ cells), while dramatic in the wild type, suggesting a beneficial role of NF-κB activation in infection.Fig. 2EAV infection is impaired in NF-κB-deficient cells. (a) Reduction of cytopathic effect (CPE). Wild-type (wt) and knockout cells were infected with EAV, and after 24 hours, cells were observed for CPE. CPE was reduced in knockout MEFs. (b) Reduction of virus titre. Virus titres were determined by plaque assay in wild-type and knockout (IKKβ^−/−^) MEFs. The virus titre was significantly reduced in NF-κB-deficient cells. (c, d, e) Impaired replication of EAV in NF-κB-deficient cells. wt and IKKβ^−/−^ MEF cells were infected with EAV at an MOI of 5, and expression of replicase (nsp3) and a structural protein (GP5) of EAV was visualized using PLA at 8 and 12 hours post-infection, respectively. Signal quantification showed a significant difference in expression of both proteins between wt and IKKβ^−/−^ cells

To further compare EAV replication in NF-κB-competent and deficient cells, the virus titer was determined in wild-type (wt) and IKKβ^−/−^ MEFs using plaque assay. Briefly, cells were incubated with duplicates of 10-fold dilutions of EAV strain SP3A for 30 minutes at 37 °C. Thereafter, cells were washed and incubated in DMEM containing 1 % agar, 2 % fetal bovine serum, 2 mM L-glutamine, 100 U/ml of penicillin and 100 μg/ml of streptomycin. Seventy-two hours later, the cells were stained with crystal violet and plaques were counted. The results showed a significantly higher virus titer in wt MEFs than in IKKβ^−/−^ MEFs (Fig. [2](#Fig2){ref-type="fig"}b), indicating a contributing role of NF-κB in EAV replication. Furthermore, the expression of key non-structural (nsp3) and structural (GP5) proteins, indicative of viral replication, was analysed by *in situ* PLA in NF-κB-competent and deficient cells. Following infection of wt and IKKβ^−/−^ MEFs at an MOI of 5, cells were fixed at 8 (for nsp3) and 12 (for GP5) hours after infection. As primary antibodies, rabbit anti-peptide serum recognizing nsp3 (1:1000 in TBS-GS) and GP5 (1:100 in TBS-GS) were used. The signals were quantified using Duolink^®^ Image Tool. As shown in the quantitation plot of Fig. [2](#Fig2){ref-type="fig"}c, and in the images of Fig. [2](#Fig2){ref-type="fig"}d and [2](#Fig2){ref-type="fig"}e, the expression of nsp3 and GP5 proteins of EAV was significantly reduced in NF-κB-deficient cells. These results further confirmed that functional NF-κB signalling is essential for efficient replication of EAV.

Activation of NF-κB in viral infections might promote viral replication \[[@CR20]\]. Replication and spread of Theiler's murine encephalomyelitis virus has been shown to be enhanced by virus-mediated NF-κB activation \[[@CR21]\]. The presence of IKKβ was also shown to be essential for lytic replication of murine gamma-hepesvirus 68 \[[@CR22]\]. However, Lee and Kleiboeker did not observe any impact of NF-κB activation on replication of porcine respiratory and reproductive syndrome virus, PRRSV (a virus related to EAV) when they suppressed NF-κB activity by overexpression of a negative form of IκBα, which sequesters NF-κB in the cytoplasm \[[@CR7]\]. Curiously, this is in contrast with our results using IKKβ^−/−^ cells that are impaired for NF-κB activation. Whether the less-efficient replication of EAV in IKKβ^−/−^ cells is due to impaired NF-κB signalling or due to the direct effect of IKKβ deficiency warrants further studies. To our knowledge, the present study is the first to reveal the contributing role of the NF-κB activity in replication of an arterivirus, a member of a virus order that includes viruses of medical and veterinary importance such as SARS coronavirus and PRRSV. A better understanding of the mechanism and the role of NF-κB activation in infections may lead to identification of potential drug targets for treatment of EVA and related viral diseases.

In summary, we present here the first report on induction of MyD88-dependent NF-κB activation by an arterivirus, EAV. We also demonstrate that EAV infection of cells impaired in NF-κB activity (IKKβ^−/−^ MEFs) is less efficient, suggesting that EAV activates NF-κB to enhance its replication. However, the molecular pathways and the mechanisms by which NF-κB activation leads to more-efficient EAV replication deserve further investigation in follow-up studies.
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